Clinical study, network pharmacology, and molecular docking of Kunxian capsule in treating idiopathic membranous nephropathy

ObjectiveA new Tripterygium wilfordii preparation called Kunxian capsule (KX) has been approved in China. However, it is still unknown whether KX is safe and effective for idiopathic membranous nephropathy (IMN) and its therapeutic mechanism of action is unclear.MethodsWe conducted a retrospective s...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Lv, Xinyu Gao, Lihua Liu, Libing He, Geng Tian, Xuehong Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1506972/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items